DYNEGY INC. (DYN) [Rocket]

News + Filings

All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Quarterly results
CC transcript
Credit agrmnt [a]
Acq. announced
Inv. presentation
Filed Chapter 11

DYNEGY INC. (DYN)

Create: Alert

All | News | Filings

Date Filed	Type	Description
04/27/2021	GN	New Preclinical Data from Dyne Therapeutics' Myotonic Dystrophy Type 1 Program to be Featured in Presentations During Upcoming American Society of Gene & Cell Therapy Annual Meeting
03/04/2021	GN	Dyne Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
01/20/2021	GN	Dyne Therapeutics Announces Pricing of $168 Million Public Offering
01/10/2021	GN	Dyne Therapeutics Myotonic Dystrophy Type 1 Program Achieves Robust RNA Knock Down of Toxic Human Nuclear DMPK in Preclinical Study
11/09/2020	GN	Dyne Therapeutics to Present at Upcoming Investor Conferences
11/05/2020	GN	Dyne Therapeutics Reports Third Quarter 2020 Financial Results and Recent Highlights
09/21/2020	GN	Dyne Therapeutics Announces Closing of Initial Public Offering
09/16/2020	GN	Dyne Therapeutics Announces Pricing of Initial Public Offering
01/24/2018	GN	SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against Dynegy Inc.
11/07/2017	GN	New Research Coverage Highlights Colgate-Palmolive, Tenet Healthcare, Mastercard, Dynegy, Symantec, and The Williams Companies – Consolidated Revenues, Company Growth, and Expectations for 2018

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy